Aegerion Pharma (AEGR) Posts Q2 Loss of 49c, Misses Views
Tweet
Share
E-mailGet Alerts AEGR Hot Sheet
Join SI Premium – FREE
Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q2 EPS of ($0.49), $0.09 worse than the analyst estimate of ($0.40).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
